Success Story: With Our Help and Premium Processing, a Research Associate from Bangladesh Secures NIW Approval

Client’s Testimonial:

“Thank you for your help and quick response during the entire process.”

On October 29^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Pharmacology and Toxicology (Approval Notice).

General Field: Pharmacology and Toxicology

Position at the Time of Case Filing: Research Associate

Country of Origin: Bangladesh

Approval Notice Date: October 29^th, 2025

Processing Time: 1 month, 21 days (Premium Processing Requested)

Case Summary:

We are excited to share the approval of an EB-2 National Interest Waiver (NIW) petition prepared by the North America Immigration Law Group for a distinguished researcher in pharmacology and toxicology. This approval was secured through premium processing and reflects the strong merit and national importance of the client’s work in advancing public health and chemical safety in the United States.

Advancing Drug and Chemical Safety in the United States

The client holds a Ph.D. in Pharmacology and Toxicology, with a focus on Environmental Toxicology, and is recognized as an expert in studying how chemicals and biologically active compounds affect the human immune system. The proposed endeavor focuses on establishing innovative toxicological testing frameworks based on human cell-derived models and multi-omics data analysis. By utilizing advanced computational, regulatory, and mechanistic approaches, the client aims to accelerate the development of safe chemical compounds and improve testing methods relied upon by government agencies and healthcare systems.

This area of research directly supports critical national goals, such as reducing adverse drug reactions, preventing harmful exposure to chemical compounds, and strengthening competitiveness in biomedical technologies, making it clearly aligned with U.S. public health priorities.

Demonstrated Record of Scholarly Excellence

The petition highlighted the client’s impactful accomplishments, including:

8 peer-reviewed journal articles (including 2 first-authored)
9 first-authored scientific abstracts
187 citations to the client’s published work, demonstrating meaningful global influence in the field

These citations reflect widespread reliance on the client’s research findings in the development of new toxicology models, immune-response studies, and pharmaceutical safety evaluations.

The petition also emphasized that the client’s expertise has been recognized through substantial research funding from highly competitive U.S. organizations. These awards underscore the value of the client’s contributions to national scientific progress.

A Strong Outcome for a Promising Research Leader

USCIS agreed that the client’s ongoing and planned work carries substantial merit and national importance and that the client is well-positioned to advance U.S. public health priorities. With this NIW approval, the client can continue driving innovation in chemical safety assessment—helping ensure safer drugs, sustainable materials, and enhanced protection for American consumers.

NAILG is proud to have supported this highly dedicated researcher in achieving this important immigration milestone. We look forward to seeing the continued expansion of their scientific impact in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.